Holen Sie sich die Stockscreener-App
0.00
33.64%
-0.0603
Paxmedica Inc Aktie (PXMD) Neueste Nachrichten
Contrasting Calliditas Therapeutics AB (publ) (NASDAQ:CALT) & PaxMedica (NASDAQ:PXMD) - Defense World
Delisting of Securities from The Nasdaq Stock Market - The Manila Times
Comparing Intra-Cellular Therapies (NASDAQ:ITCI) and PaxMedica (NASDAQ:PXMD) - Defense World
Kuvatris Therapeutics Renames, Cancels Shares Amid Restructuring - AInvest
PaxMedica Renames to Kuvatris, Cancels Shares - TipRanks
PaxMedica Provides Company Update and Continues to Advance PAX-101 Regulatory Strategy - marketscreener.com
Press Release Distribution & PR Platform - ACCESS Newswire
PaxMedica announces board resignations amid transition - Investing.com
PaxMedica Announces Board Chairman Resignation Amid Transition - TipRanks
PaxMedica Holds Important FDA Type-B Meeting to Review PAX-101 Pivotal Trial Data - ACCESS Newswire
PaxMedica Announces Resignation of Key Executives - TipRanks
PaxMedica Reports First Patient Treated with PAX-101 for Fatal African Sleeping Sickness Infection - ACCESS Newswire
PaxMedica Announces First Patent Allowance for Suramin Intranasal Formulation in the treatment of Autism Spectrum Disorder and Other Conditions - ACCESS Newswire
Craft Capital Management Announces Pricing of Initial Public Offering for PaxMedica, Inc. - ACCESS Newswire
PaxMedica Secures Immediate Exercise of Warrants - ACCESS Newswire
PaxMedica, Inc. (PXMD) Stock Price, News, Quote & History - Yahoo
PaxMedica Secures Groundbreaking China Patent for Autism Treatment Breakthrough After 100 Years - Stock Titan
Autism Prevalence Surges Globally, Raising Concerns Among Healthcare Experts - FinancialContent
BioMedNewsBreaks — PaxMedica Inc. (PXMD) Announces Immediate Exercise of Warrants to Total Approximately $884K | Dow Theory Letters - FinancialContent
BioMedNewsBreaks — PaxMedica Inc. (PXMD) Intensifying Efforts to Achieve Significant Program Milestones - FinancialContent
Researchers Say Brain ‘Overgrowth’ Could Contribute to Autism Development - FinancialContent
Silicon Valley - FinancialContent
PaxMedica (NASDAQ: PXMD) Seeking to Qualify for Neglected Tropical Disease Priority Review Voucher - Barchart.com
BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Dedicated to Ensuring Access to Life-Saving Treatments - FinancialContent
PaxMedica Files Nasdaq Delisting Appeal Notice and Prepares for Upcoming FDA Meeting on PAX-101 - Yahoo Finance
PXMD Stock Price and Chart — OTC:PXMD - TradingView
PaxMedica Inc. (NASDAQ: PXMD) Announces PAX-101 Batch Completion for NDA Application to FDA - FinancialContent
PaxMedica's CEO and Malawi Health Official Discuss Urgent Medical Crisis in Bell2Bell Podcast - Yahoo Finance
As Autism Cases Rise, Biopharma Springs Into Action - BioSpace
PaxMedica Responds to Emergency Request for IV Suramin and Commits to Provide Immediate Access to PAX-101 - GlobeNewswire
Malawi’s Health Ministry Seeks Emergency Access to PaxMedica’s IV Suramin - NAVLIN DAILY
PaxMedica Receives Emergency Request for IV Suramin from African Health Ministry for Use in Treating Fatal Sleeping Sickness - Yahoo Finance
Why Is PaxMedica (PXMD) Stock Up 93% Today? - InvestorPlace
PaxMedica Achieves Key Milestone in the Development of - GlobeNewswire
PaxMedica Updated Company Presentation Highlighting Innovations in Autism Spectrum Disorder Treatments - GlobeNewswire
PaxMedica Accelerates RSU Vesting for Top Executives - TipRanks
PaxMedica (NASDAQ: PXMD) Dedicated to Enhancing Quality of Life for Individuals with ASD - The Globe and Mail
PaxMedica Releases Fireside Chat Video with CEO Howard Weisman - StreetInsider
HC Wainwright & Co. Initiates Coverage of PaxMedica (PXMD) with Buy Recommendation - Nasdaq
PaxMedica (NASDAQ: PXMD) Closes on Public Offering Reaching Estimated $7M - The Globe and Mail
Penny Stocks To Buy? 5 To Watch Right Now - PennyStocks.com
PaxMedica News of FDA Type-B Meeting Shared in Audio Broadcast - Yahoo Finance
PaxMedica (NASDAQ: PXMD) News of FDA Type-B Meeting Shared in Audio Broadcast - The Globe and Mail
PaxMedica Releases Q3 2023 Financial Report, Corporate Update - Yahoo Finance
What LIFW, PXMD, and NVOS have in common - StocksToTrade
Why Is PaxMedica (PXMD) Stock Up 95% Today? - InvestorPlace
PaxMedica Engages Bourne Partners to Explore Future Monetization of Potential Priority Review Voucher (PRV) - FinancialContent
PaxMedica (NASDAQ: PXMD) to jump 1,700% todaypurely nominal and technical - Dhaka Tribune
PaxMedica Announces 1-for-17 Reverse Stock Split - Yahoo Finance
Thinking about buying stock in Nextplay Technologies, ABVC Biopharma, PaxMedica, Mustang Bio, or NXU Inc.? - MarketScreener
Why Is PaxMedica (PXMD) Stock Up Today? - TradingView
PaxMedica Announces Gold Sponsorship of The BRAIN Foundation's Synchrony Symposia 2023 - Yahoo Finance
PaxMedica, Inc. Announces Second Quarter 2023 Financial Results and Business Update - Yahoo Finance
PaxMedica Announces Positive Top Line Results from the PAX-101 (intravenous suramin) Phase 3 African Sleeping Sickness Study, PAX-HAT-301 - Yahoo Finance
PaxMedica Comments on Common Stock Volatility - Yahoo Finance
PaxMedica CEO Interviewed by The BRAIN Foundation - GlobeNewswire
PaxMedica seeks SAHPRA approval to initiate ASD therapy trial - Clinical Trials Arena
PaxMedica Submits Clinical Trial Request in Autism Spectrum Disorder - GlobeNewswire
PaxMedica and PoloMar to investigate emodin in ASD trial - Clinical Trials Arena
PaxMedica Enters Research Collaboration Agreement With - GlobeNewswire
PaxMedica Completes HAT-301 Registrational Trial for PAX-101 - GlobeNewswire
PaxMedica, Inc. Provides First Quarter 2023 Business Update; Phase 3 HAT-301 Top Line Results Expected in Second Half 2023 - Yahoo Finance
PaxMedica Announces NASDAQ Closing Bell Ringing to Celebrate Initial Public Offering and Autism Awareness Month - Yahoo Finance
5 Short Squeeze Stocks To Watch: Getty Images, PaxMedica, A Mental Health Care Company And More By Benzinga - Investing.com UK
Autistic Disorder Clinical Trial Pipeline Insights Featuring 25+ Companies | DelveInsight - GlobeNewswire
PaxMedica Signs $3.2 Million Funding Deal With Lind Global Partners; Shares Rise - MarketScreener
PaxMedica Releases 2022 Shareholder Letter - Yahoo Finance
PaxMedica to Present at the Jan 26th Virtual Investor Summit Microcap Event - Yahoo Finance
Pre-market Movers: FUV, CYAD, ATXI, CSSE, PXMD… - Nasdaq
PaxMedica, Inc. Launches Updated Corporate Website at - GlobeNewswire
PaxMedica, Inc. (PXMD) stock price, news, quote and history - Yahoo
PaxMedica to Present at the Benchmark Company’s Upcoming Discovery One-on-One Investor Conference - GlobeNewswire
1.11%
0.29%
Kapitalisierung:
|
Volumen (24h):